Surgical treatment of syringomyelia. Favorable results with syringoperitoneal shunting

Nicholas Barbaro, C. B. Wilson, P. H. Gutin, M. S B Edwards

Research output: Contribution to journalArticle

133 Citations (Scopus)

Abstract

The authors reviewed the clinical findings, radiological evaluation, and operative therapy of 39 patients with syringomyelia. Syringoperitoneal (SP) shunting was used in 15 patients and other procedures were used in 24 patients. Follow-up periods ranged from 1 1/2 to 12 years. During the period of this study, metrizamide myelography in conjunction with early and delayed computerized tomography scanning replaced all other diagnostic procedures in patients with syringomyelia. Preoperative accuracy for the two procedures was 87%. The most common symptoms were weakness (79%), sensory loss (67%), pain (38%), and leg stiffness (28%). Surgery was most effective in stabilizing or alleviating pain (100%), sensory loss (81%), and weakness (74%); spasticity, headache, and bowel or bladder dysfunction were less likely to be reversed. Approximately 80% of patients with idiopathic and posttraumatic syringomyelia and 70% of those with arachnoiditis improved or stabilized. Better results were obtained in patients with less severe neurological deficits, suggesting the need for early operative intervention. A higher percentage of patients had neurological improvement with SP shunting than with any other procedure, espcially when SP shunting was the first operation performed. Patients treated with SP shunts also had the highest complication rate, most often shunt malfunction. These results indicate that SP shunting is effective in reversing or arresting neurological deterioration in patients with syringomyelia.

Original languageEnglish (US)
Pages (from-to)531-538
Number of pages8
JournalJournal of Neurosurgery
Volume61
Issue number3
StatePublished - 1984
Externally publishedYes

Fingerprint

Syringomyelia
Therapeutics
Arachnoiditis
Metrizamide
Pain
Myelography
Headache
Leg
Urinary Bladder
Tomography

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Barbaro, N., Wilson, C. B., Gutin, P. H., & Edwards, M. S. B. (1984). Surgical treatment of syringomyelia. Favorable results with syringoperitoneal shunting. Journal of Neurosurgery, 61(3), 531-538.

Surgical treatment of syringomyelia. Favorable results with syringoperitoneal shunting. / Barbaro, Nicholas; Wilson, C. B.; Gutin, P. H.; Edwards, M. S B.

In: Journal of Neurosurgery, Vol. 61, No. 3, 1984, p. 531-538.

Research output: Contribution to journalArticle

Barbaro, N, Wilson, CB, Gutin, PH & Edwards, MSB 1984, 'Surgical treatment of syringomyelia. Favorable results with syringoperitoneal shunting', Journal of Neurosurgery, vol. 61, no. 3, pp. 531-538.
Barbaro, Nicholas ; Wilson, C. B. ; Gutin, P. H. ; Edwards, M. S B. / Surgical treatment of syringomyelia. Favorable results with syringoperitoneal shunting. In: Journal of Neurosurgery. 1984 ; Vol. 61, No. 3. pp. 531-538.
@article{3e2d638b5dde4012ae0567abf0c3903b,
title = "Surgical treatment of syringomyelia. Favorable results with syringoperitoneal shunting",
abstract = "The authors reviewed the clinical findings, radiological evaluation, and operative therapy of 39 patients with syringomyelia. Syringoperitoneal (SP) shunting was used in 15 patients and other procedures were used in 24 patients. Follow-up periods ranged from 1 1/2 to 12 years. During the period of this study, metrizamide myelography in conjunction with early and delayed computerized tomography scanning replaced all other diagnostic procedures in patients with syringomyelia. Preoperative accuracy for the two procedures was 87{\%}. The most common symptoms were weakness (79{\%}), sensory loss (67{\%}), pain (38{\%}), and leg stiffness (28{\%}). Surgery was most effective in stabilizing or alleviating pain (100{\%}), sensory loss (81{\%}), and weakness (74{\%}); spasticity, headache, and bowel or bladder dysfunction were less likely to be reversed. Approximately 80{\%} of patients with idiopathic and posttraumatic syringomyelia and 70{\%} of those with arachnoiditis improved or stabilized. Better results were obtained in patients with less severe neurological deficits, suggesting the need for early operative intervention. A higher percentage of patients had neurological improvement with SP shunting than with any other procedure, espcially when SP shunting was the first operation performed. Patients treated with SP shunts also had the highest complication rate, most often shunt malfunction. These results indicate that SP shunting is effective in reversing or arresting neurological deterioration in patients with syringomyelia.",
author = "Nicholas Barbaro and Wilson, {C. B.} and Gutin, {P. H.} and Edwards, {M. S B}",
year = "1984",
language = "English (US)",
volume = "61",
pages = "531--538",
journal = "Journal of Neurosurgery",
issn = "0022-3085",
publisher = "American Association of Neurological Surgeons",
number = "3",

}

TY - JOUR

T1 - Surgical treatment of syringomyelia. Favorable results with syringoperitoneal shunting

AU - Barbaro, Nicholas

AU - Wilson, C. B.

AU - Gutin, P. H.

AU - Edwards, M. S B

PY - 1984

Y1 - 1984

N2 - The authors reviewed the clinical findings, radiological evaluation, and operative therapy of 39 patients with syringomyelia. Syringoperitoneal (SP) shunting was used in 15 patients and other procedures were used in 24 patients. Follow-up periods ranged from 1 1/2 to 12 years. During the period of this study, metrizamide myelography in conjunction with early and delayed computerized tomography scanning replaced all other diagnostic procedures in patients with syringomyelia. Preoperative accuracy for the two procedures was 87%. The most common symptoms were weakness (79%), sensory loss (67%), pain (38%), and leg stiffness (28%). Surgery was most effective in stabilizing or alleviating pain (100%), sensory loss (81%), and weakness (74%); spasticity, headache, and bowel or bladder dysfunction were less likely to be reversed. Approximately 80% of patients with idiopathic and posttraumatic syringomyelia and 70% of those with arachnoiditis improved or stabilized. Better results were obtained in patients with less severe neurological deficits, suggesting the need for early operative intervention. A higher percentage of patients had neurological improvement with SP shunting than with any other procedure, espcially when SP shunting was the first operation performed. Patients treated with SP shunts also had the highest complication rate, most often shunt malfunction. These results indicate that SP shunting is effective in reversing or arresting neurological deterioration in patients with syringomyelia.

AB - The authors reviewed the clinical findings, radiological evaluation, and operative therapy of 39 patients with syringomyelia. Syringoperitoneal (SP) shunting was used in 15 patients and other procedures were used in 24 patients. Follow-up periods ranged from 1 1/2 to 12 years. During the period of this study, metrizamide myelography in conjunction with early and delayed computerized tomography scanning replaced all other diagnostic procedures in patients with syringomyelia. Preoperative accuracy for the two procedures was 87%. The most common symptoms were weakness (79%), sensory loss (67%), pain (38%), and leg stiffness (28%). Surgery was most effective in stabilizing or alleviating pain (100%), sensory loss (81%), and weakness (74%); spasticity, headache, and bowel or bladder dysfunction were less likely to be reversed. Approximately 80% of patients with idiopathic and posttraumatic syringomyelia and 70% of those with arachnoiditis improved or stabilized. Better results were obtained in patients with less severe neurological deficits, suggesting the need for early operative intervention. A higher percentage of patients had neurological improvement with SP shunting than with any other procedure, espcially when SP shunting was the first operation performed. Patients treated with SP shunts also had the highest complication rate, most often shunt malfunction. These results indicate that SP shunting is effective in reversing or arresting neurological deterioration in patients with syringomyelia.

UR - http://www.scopus.com/inward/record.url?scp=0021259601&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021259601&partnerID=8YFLogxK

M3 - Article

C2 - 6747690

AN - SCOPUS:0021259601

VL - 61

SP - 531

EP - 538

JO - Journal of Neurosurgery

JF - Journal of Neurosurgery

SN - 0022-3085

IS - 3

ER -